Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000132

President and CEO acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Brunn Carsten President and CEO 2021-10-01 Grant or award +37,500 294,072 D
Loading xslF345X03/wf-form4_163346550161233.xml…